| |||||||||
Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Background Strain B6.129P2-Il10tm1Cgn/JLt Donor Strain C3H/HeJBir Generation N10F3pN1 Appearance
black
Related Genotype: a/aDescription
Homozygous mice are IL10-deficient and develop spontaneous colitic lesions in the cecum and large intestine as early as 6-8 weeks of age. The severity and age of onset of colitis varies with the donor type and location of the cytokine deficiency colitis susceptibility 1 (Cdcs1) interval. Generally, the C3H/HeJBir region encompassed by D3Mit348 through D3Mit254 (127.7-132.5 megabases) confers increased colitis susceptibility on the B6.129P2-Il10tm1Cgn background (Beckwith J, et al., 2005). Mice on the B6.129P2-Il10tm1Cgn background are prone to rectal prolapse particularly when carrying susceptibility alleles from Chromosome 3. Granulocyte populations in peripheral blood increase upon lesion development and provide a robust non-lethal assessment of colitis severity.Development
A panel of reciprocal congenic stocks was generated by a marker assisted "speed congenic" approach. C3Bir.129P2(B6)-Il10tm1Cgn/Lt (Stock No. 004326) mice were backcrossed to B6.129P2-Il10tm1Cgn/JLt for 10 (N10) generations. Progeny were selected for a C3H/HeJBir donor interval within Cdcs1. This strain (Stock No. 005912) is called "BC-R2" in the primary reference (Beckwith 2005 Gastroenterology 129:1473), and contains the C3H/HeJBir donor interval defined by D3Mit49-D3Mit348. Of note, the BC-R2 mice described in Beckwith 2005 were backcrossed to B6.129P2-Il10tm1Cgn/JLt between 4-6 generations (N4-N6) generations.
| Control | ||
|---|---|---|
| 002251 B6.129P2-Il10tm1Cgn/J | (approximate) | |
| Considerations for Choosing Controls | ||
Strains carrying Il10tm1Cgn allele
004368 129(B6)-Il10tm1Cgn/J 002250 B10.129P2(B6)-Il10tm1Cgn/J 002251 B6.129P2-Il10tm1Cgn/J 004333 C.129P2(B6)-Il10tm1Cgn/J 004326 C3Bir.129P2(B6)-Il10tm1Cgn/Lt 003968 C3Bir.129P2(B6)-Il10tm1Cgn/LtJ 005346 NOD.Cg-Il10tm1Cgn Casp1tm1Sesh/LtJ 004228 NOD.Cg-Il10tm1Cgn Il4tm1Cgn/Dvs 004291 NOD.Cg-Il10tm1Cgn Il4tm1Cgn/DvsJ 004266 NOD.Cg-Il10tm1Cgn/DvsJ View Strains carrying Il10tm1Cgn (10 strains)
Congenic Nomenclature
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Cdcs1C3H/HeJBir/Cdcs1C3H/HeJBir
involves: B6.129P2-Il10tm1Cgn/Lt * C3Bir.129P2(B6)-Il10tm1Cgn/Lt
- digestive/alimentary phenotype
- abnormal digestive system morphology (MGI Ref ID J:72978)
- colitis
- immune system phenotype
- abnormal immune system physiology (MGI Ref ID J:72978)
- susceptibility to colitis
Cdcs1C3H/HeJBir/Cdcs1C57BL/6J
involves: C3H/HeJBir-Il10tm1Cgn * C57BL/6J-Il10tm1CgnView Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Il10tm1Cgn relatedInternal/Organ Research
Gastrointestinal Defects (colitis)
Cancer Research
Growth Factors/Receptors/Cytokines
Hematological Research
Anemia, Iron Deficiency and Transport Defects (hemolytic)
Immunological Defects
Immunology and Inflammation Research
Autoimmunity
Growth Factors/Receptors/Cytokines
Immunodeficiency
Inflammation (Inflammatory bowel disease)
| Allele Symbol | Il10tm1Cgn | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, University of Cologne | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | IL-10 KO; IL-10-; IL-10KO; IL-10KO; Il10-; Il10tmCgn; | ||
| Mutation Made By | Ralf Kuhn, University of Cologne | ||
| Strain of Origin | 129P2/OlaHsd | ||
| ES Cell Line Name | E14.1 | ||
| ES Cell Line Strain | 129P2/OlaHsd | ||
| Gene Symbol and Name | Il10, interleukin 10 | ||
| Chromosome | 1 | ||
| Gene Common Name(s) | CSIF; IL-10; IL10A; IL10X; Il-10; MGC126450; MGC126451; TGIF; cytokine synthesis inhibitory factor; | ||
| Molecular Note | A 500 bp genomic fragment containing codons 5-55 was replaced with a linker containing a termination codon followed by a neomycin cassette. A termination codon was also introduced into exon 3. No IL10 activity was detectable in ELISA assays in supernatants of in vitro splenic T cells derived from homozygous mice. | ||
| Gene Symbol and Name | D3Mit348, DNA Segment, Chr 3 Massachusetts Institute of Technology 348 | ||
| Chromosome | 3 | ||
| Gene Symbol and Name | D3Mit49, DNA segment, Chr 3, Massachusetts Institute of Technology 49 | ||
| Chromosome | 3 | ||
| Allele Symbol | Cdcs1C3H/HeJBir | ||
| Allele Name | C3H/HeJBir | ||
| Allele Type | QTL | ||
| Strain of Origin | C3Bir.129P2(B6)-Il10tm1Cgn/Lt | ||
| Gene Symbol and Name | Cdcs1, cytokine deficiency colitis susceptibility 1 | ||
| Chromosome | 3 | ||
Genotyping Protocols
Il10tm1Cgn, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Beckwith J; Cong Y; Sundberg JP; Elson CO; Leiter EH. 2005. Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens. Gastroenterology 129(5):1473-84. [PubMed: 16285949] [MGI Ref ID J:101721]
Farmer MA; Sundberg JP; Bristol IJ; Churchill GA; Li R; Elson CO; Leiter EH. 2001. A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc Natl Acad Sci U S A 98(24):13820-5. [PubMed: 11707574] [MGI Ref ID J:72978]
Bleich A; Mahler M; Most C; Leiter EH; Liebler-Tenorio E; Elson CO; Hedrich HJ; Schlegelberger B; Sundberg JP. 2004. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm Genome 15(11):865-71. [PubMed: 15672590] [MGI Ref ID J:94027]
Cdcs1C3H/HeJBir relatedIl10tm1Cgn relatedBleich A; Mahler M; Most C; Leiter EH; Liebler-Tenorio E; Elson CO; Hedrich HJ; Schlegelberger B; Sundberg JP. 2004. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm Genome 15(11):865-71. [PubMed: 15672590] [MGI Ref ID J:94027]
Akhiani AA; Stensson A; Schon K; Lycke NY. 2005. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. J Immunol 174(12):8144-53. [PubMed: 15944323] [MGI Ref ID J:100891]
Aliberti J; Viola JP; Vieira-de-Abreu A; Bozza PT; Sher A; Scharfstein J. 2003. Cutting edge: Bradykinin induces IL-12 production by dendritic cells: a danger signal that drives Th1 polarization. J Immunol 170(11):5349-53. [PubMed: 12759407] [MGI Ref ID J:83453]
Allen HL; Deepe GS Jr. 2005. Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum. J Clin Invest 115(10):2875-85. [PubMed: 16151533] [MGI Ref ID J:101533]
Allen HL; Deepe GS Jr. 2006. B cells and CD4-CD8- T cells are key regulators of the severity of reactivation histoplasmosis. J Immunol 177(3):1763-71. [PubMed: 16849486] [MGI Ref ID J:138028]
Almeida AR; Legrand N; Papiernik M; Freitas AA. 2002. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 169(9):4850-60. [PubMed: 12391195] [MGI Ref ID J:125748]
Amante FH; Stanley AC; Randall LM; Zhou Y; Haque A; McSweeney K; Waters AP; Janse CJ; Good MF; Hill GR; Engwerda CR. 2007. A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am J Pathol 171(2):548-59. [PubMed: 17600128] [MGI Ref ID J:123927]
Ameredes BT; Sethi JM; Liu HL; Choi AM; Calhoun WJ. 2005. Enhanced nitric oxide production associated with airway hyporesponsiveness in the absence of IL-10. Am J Physiol Lung Cell Mol Physiol 288(5):L868-73. [PubMed: 15618456] [MGI Ref ID J:115459]
Ameredes BT; Zamora R; Gibson KF; Billiar TR; Dixon-McCarthy B; Watkins S; Calhoun WJ. 2001. Increased nitric oxide production by airway cells of sensitized and challenged IL-10 knockout mice. J Leukoc Biol 70(5):730-6. [PubMed: 11698492] [MGI Ref ID J:124461]
Ameredes BT; Zamora R; Sethi JM; Liu HL; Kohut LK; Gligonic AL; Choi AM; Calhoun WJ. 2005. Alterations in nitric oxide and cytokine production with airway inflammation in the absence of IL-10. J Immunol 175(2):1206-13. [PubMed: 16002724] [MGI Ref ID J:100726]
Ananieva O; Darragh J; Johansen C; Carr JM; McIlrath J; Park JM; Wingate A; Monk CE; Toth R; Santos SG; Iversen L; Arthur JS. 2008. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol 9(9):1028-36. [PubMed: 18690222] [MGI Ref ID J:139576]
Anderson AC; Reddy J; Nazareno R; Sobel RA; Nicholson LB; Kuchroo VK. 2004. IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J Immunol 173(2):828-34. [PubMed: 15240669] [MGI Ref ID J:91913]
Anderson CF; Oukka M; Kuchroo VJ; Sacks D. 2007. CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204(2):285-97. [PubMed: 17283207] [MGI Ref ID J:125372]
Andrassy M; Igwe J; Autschbach F; Volz C; Remppis A; Neurath MF; Schleicher E; Humpert PM; Wendt T; Liliensiek B; Morcos M; Schiekofer S; Thiele K; Chen J; Kientsch-Engel R; Schmidt AM; Stremmel W; Stern DM; Katus HA; Nawroth PP; Bierhaus A. 2006. Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am J Pathol 169(4):1223-37. [PubMed: 17003481] [MGI Ref ID J:113376]
Apte RS; Richter J; Herndon J; Ferguson TA. 2006. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med 3(8):e310. [PubMed: 16903779] [MGI Ref ID J:134144]
Arsenescu R; Blum AM; Metwali A; Elliott DE; Weinstock JV. 2005. IL-12 induction of mRNA encoding substance P in murine macrophages from the spleen and sites of inflammation. J Immunol 174(7):3906-11. [PubMed: 15778345] [MGI Ref ID J:110005]
Auerbuch V; Isberg RR. 2007. Growth of Yersinia pseudotuberculosis in Mice Occurs Independently of Toll-Like Receptor 2 Expression and Induction of Interleukin-10. Infect Immun 75(7):3561-70. [PubMed: 17420232] [MGI Ref ID J:122417]
Awasthi A; Carrier Y; Peron JP; Bettelli E; Kamanaka M; Flavell RA; Kuchroo VK; Oukka M; Weiner HL. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8(12):1380-9. [PubMed: 17994022] [MGI Ref ID J:127774]
Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N. 2000. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes J Immunol 165(12):7330-7. [PubMed: 11120869] [MGI Ref ID J:66103]
Balasa B; Van Gunst K; Jung N; Katz JD; Sarvetnick N. 2000. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse. Cell Immunol 202(2):97-102. [PubMed: 10896769] [MGI Ref ID J:114170]
Bandukwala HS; Clay BS; Tong J; Mody PD; Cannon JL; Shilling RA; Verbeek JS; Weinstock JV; Solway J; Sperling AI. 2007. Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation. J Exp Med 204(8):1875-89. [PubMed: 17664287] [MGI Ref ID J:125951]
Beenhouwer DO; Shapiro S; Feldmesser M; Casadevall A; Scharff MD. 2001. Both Th1 and Th2 Cytokines Affect the Ability of Monoclonal Antibodies To Protect Mice against Cryptococcus neoformans. Infect Immun 69(10):6445-55. [PubMed: 11553589] [MGI Ref ID J:71570]
Beissert S; Hosoi J; Kuhn R; Rajewsky K; Muller W; Granstein RD. 1996. Impaired immunosuppressive response to ultraviolet radiation in interleukin-10-deficient mice. J Invest Dermatol 107(4):553-7. [PubMed: 8823360] [MGI Ref ID J:35510]
Beiting DP; Bliss SK; Schlafer DH; Roberts VL; Appleton JA. 2004. Interleukin-10 limits local and body cavity inflammation during infection with muscle-stage Trichinella spiralis. Infect Immun 72(6):3129-37. [PubMed: 15155614] [MGI Ref ID J:90250]
Belkaid Y; Hoffmann KF; Mendez S; Kamhawi S; Udey MC; Wynn TA; Sacks DL. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 194(10):1497-506. [PubMed: 11714756] [MGI Ref ID J:118003]
Berg DJ; Davidson N; Kuhn R; Muller W; Menon S; Holland G; Thompson-Snipes L; Leach MW; Rennick D. 1996. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98(4):1010-20. [PubMed: 8770874] [MGI Ref ID J:35020]
Berg DJ; Leach MW; Kuhn R; Rajewsky K; Muller W; Davidson NJ; Rennick D. 1995. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 182(1):99-108. [PubMed: 7790826] [MGI Ref ID J:26221]
Bernert H; Sekikawa K; Radcliffe RA; Iraqi F; You M; Malkinson AM. 2003. Tnfa and Il-10 deficiencies have contrasting effects on lung tumor susceptibility: Gender-dependent modulation of IL-10 haploinsufficiency. Mol Carcinog 38(3):117-23. [PubMed: 14587096] [MGI Ref ID J:86489]
Bettelli E; Das MP; Howard ED; Weiner HL; Sobel RA; Kuchroo VK. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 161(7):3299-306. [PubMed: 9759845] [MGI Ref ID J:115204]
Biburger M; Tiegs G. 2008. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors. J Leukoc Biol 84(1):264-79. [PubMed: 18407967] [MGI Ref ID J:137749]
Bliss SK; Alcaraz A; Appleton JA. 2003. IL-10 prevents liver necrosis during murine infection with Trichinella spiralis. J Immunol 171(6):3142-7. [PubMed: 12960341] [MGI Ref ID J:85372]
Blois SM; Ilarregui JM; Tometten M; Garcia M; Orsal AS; Cordo-Russo R; Toscano MA; Bianco GA; Kobelt P; Handjiski B; Tirado I; Markert UR; Klapp BF; Poirier F; Szekeres-Bartho J; Rabinovich GA; Arck PC. 2007. A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 13(12):1450-7. [PubMed: 18026113] [MGI Ref ID J:130208]
Blum A; Setiawan T; Hang L; Stoyanoff K; Weinstock JV. 2008. Interleukin-12 (IL-12) and IL-23 induction of substance p synthesis in murine T cells and macrophages is subject to IL-10 and transforming growth factor beta regulation. Infect Immun 76(8):3651-6. [PubMed: 18505813] [MGI Ref ID J:139373]
Bosschaerts T; Guilliams M; Noel W; Herin M; Burk RF; Hill KE; Brys L; Raes G; Ghassabeh GH; De Baetselier P; Beschin A. 2008. Alternatively activated myeloid cells limit pathogenicity associated with African trypanosomiasis through the IL-10 inducible gene selenoprotein P. J Immunol 180(9):6168-75. [PubMed: 18424738] [MGI Ref ID J:134536]
Bristol IJ; Farmer MA; Cong Y; Zheng XX; Strom TB; Elson CO; Sundberg JP; Leiter EH. 2000. Heritable susceptibility for colitis in mice induced by IL-10 deficiency. Inflamm Bowel Dis 6(4):290-302. [PubMed: 11149562] [MGI Ref ID J:109882]
Brooks DG; Trifilo MJ; Edelmann KH; Teyton L; McGavern DB; Oldstone MB. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12(11):1301-9. [PubMed: 17041596] [MGI Ref ID J:115332]
Bundoc VG; Keane-Myers A. 2007. IL-10 confers protection from mast cell degranulation in a mouse model of allergic conjunctivitis. Exp Eye Res 85(4):575-9. [PubMed: 17765892] [MGI Ref ID J:126367]
Burich A; Hershberg R; Waggie K; Zeng W; Brabb T; Westrich G; Viney JL; Maggio-Price L. 2001. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol 281(3):G764-78. [PubMed: 11518689] [MGI Ref ID J:108283]
Buxbaum LU; Scott P. 2005. Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions. Infect Immun 73(4):2101-8. [PubMed: 15784551] [MGI Ref ID J:97206]
Cain JA; Smith JA; Ondr JK; Wang B; Katz JD. 2006. NKT cells and IFN-gamma establish the regulatory environment for the control of diabetogenic T cells in the nonobese diabetic mouse. J Immunol 176(3):1645-54. [PubMed: 16424194] [MGI Ref ID J:126603]
Caligiuri G; Rudling M; Ollivier V; Jacob MP; Michel JB; Hansson GK; Nicoletti A. 2003. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 9(1-2):10-7. [PubMed: 12765335] [MGI Ref ID J:105858]
Cantorna MT; Munsick C; Bemiss C; Mahon BD. 2000. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease J Nutr 130(11):2648-52. [PubMed: 11053501] [MGI Ref ID J:65513]
Carregaro V; Valenzuela JG; Cunha TM; Verri WA Jr; Grespan R; Matsumura G; Ribeiro JM; Elnaiem DE; Silva JS; Cunha FQ. 2008. Phlebotomine salivas inhibit immune inflammation-induced neutrophil migration via an autocrine DC-derived PGE2/IL-10 sequential pathway. J Leukoc Biol 84(1):104-14. [PubMed: 18390928] [MGI Ref ID J:137750]
Carrero JA; Calderon B; Unanue ER. 2006. Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J Exp Med 203(4):933-40. [PubMed: 16549598] [MGI Ref ID J:123753]
Carroll IM; Andrus JM; Bruno-Barcena JM; Klaenhammer TR; Hassan HM; Threadgill DS. 2007. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 293(4):G729-38. [PubMed: 17640978] [MGI Ref ID J:126666]
Chelvarajan L; Popa D; Liu Y; Getchell TV; Stromberg AJ; Bondada S. 2007. Molecular mechanisms underlying anti-inflammatory phenotype of neonatal splenic macrophages. J Leukoc Biol 82(2):403-16. [PubMed: 17495050] [MGI Ref ID J:123516]
Chen W; Shu D; Chadwick VS. 2001. Helicobacter pylori infection: mechanism of colonization and functional dyspepsia Reduced colonization of gastric mucosa by Helicobacter pylori in mice deficient in interleukin-10. J Gastroenterol Hepatol 16(4):377-83. [PubMed: 11354274] [MGI Ref ID J:103513]
Chiaramonte MG; Hesse M; Cheever AW; Wynn TA. 2000. CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism. J Immunol 164(2):973-85. [PubMed: 10623847] [MGI Ref ID J:127058]
Chiaramonte MG; Mentink-Kane M; Jacobson BA; Cheever AW; Whitters MJ; Goad ME; Wong A; Collins M; Donaldson DD; Grusby MJ; Wynn TA. 2003. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med 197(6):687-701. [PubMed: 12642601] [MGI Ref ID J:124413]
Chmiel JF; Konstan MW; Saadane A; Krenicky JE; Lester Kirchner H; Berger M. 2002. Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice. Am J Respir Crit Care Med 165(8):1176-81. [PubMed: 11956064] [MGI Ref ID J:103028]
Clemons KV; Grunig G; Sobel RA; Mirels LF; Rennick DM; Stevens DA. 2000. Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis Clin Exp Immunol 122(2):186-91. [PubMed: 11091273] [MGI Ref ID J:65686]
Czarneski J; Lin YC; Chong S; McCarthy B; Fernandes H; Parker G; Mansour A; Huppi K; Marti GE; Raveche E. 2004. Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma. Leukemia 18(3):597-606. [PubMed: 14712288] [MGI Ref ID J:88136]
D'Orazio TJ; Niederkorn JY. 1998. A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol 160(5):2089-98. [PubMed: 9498745] [MGI Ref ID J:111362]
Dai WJ; Kohler G; Brombacher F. 1997. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J Immunol 158(5):2259-67. [PubMed: 9036973] [MGI Ref ID J:110855]
Das G; Augustine MM; Das J; Bottomly K; Ray P; Ray A. 2003. An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc Natl Acad Sci U S A 100(9):5324-9. [PubMed: 12695566] [MGI Ref ID J:83283]
Davidson NJ; Fort MM; Muller W; Leach MW; Rennick DM. 2000. Chronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response Int Rev Immunol 19(1):91-121. [PubMed: 10723680] [MGI Ref ID J:61253]
Davidson NJ; Leach MW; Fort MM; Thompson-Snipes L; Kuhn R; Muller W; Berg DJ; Rennick DM. 1996. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 184(1):241-51. [PubMed: 8691138] [MGI Ref ID J:34035]
De Fazio SR; Gozzo JJ. 2000. Role of graft interleukin-10 expression in the tolerogenicity of neonatal skin allografts Transplantation 70(9):1371-7. [PubMed: 11087155] [MGI Ref ID J:65782]
Deepe GS Jr; Gibbons RS. 2003. Protective and memory immunity to Histoplasma capsulatum in the absence of IL-10. J Immunol 171(10):5353-62. [PubMed: 14607938] [MGI Ref ID J:117988]
Del Sero G; Mencacci A; Cenci E; d'Ostiani CF; Montagnoli C; Bacci A; Mosci P; Kopf M; Romani L. 1999. Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect 1(14):1169-80. [PubMed: 10580272] [MGI Ref ID J:106542]
Demangel C; Bertolino P; Britton WJ. 2002. Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur J Immunol 32(4):994-1002. [PubMed: 11920565] [MGI Ref ID J:75998]
Demols A; Van Laethem JL; Quertinmont E; Degraef C; Delhaye M; Geerts A; Deviere J. 2002. Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 282(6):G1105-12. [PubMed: 12016137] [MGI Ref ID J:108286]
Denning TL; Wang YC; Patel SR; Williams IR; Pulendran B. 2007. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 8(10):1086-94. [PubMed: 17873879] [MGI Ref ID J:125258]
Dercamp C; Chemin K; Caux C; Trinchieri G; Vicari AP. 2005. Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses. Cancer Res 65(18):8479-86. [PubMed: 16166328] [MGI Ref ID J:101610]
Di Marco R; Xiang M; Zaccone P; Leonardi C; Franco S; Meroni P; Nicoletti F. 1999. Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency Autoimmunity 31(2):75-83. [PubMed: 10680745] [MGI Ref ID J:60463]
DiFedele LM; He J; Bonkowski EL; Han X; Held MA; Bohan A; Menon RK; Denson LA. 2005. Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis. Gastroenterology 128(5):1278-91. [PubMed: 15887111] [MGI Ref ID J:124938]
Dieleman LA; Arends A; Tonkonogy SL; Goerres MS; Craft DW; Grenther W; Sellon RK; Balish E; Sartor RB. 2000. Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect Immun 68(9):5107-13. [PubMed: 10948132] [MGI Ref ID J:64076]
Dresner-Pollak R; Gelb N; Rachmilewitz D; Karmeli F; Weinreb M. 2004. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology 127(3):792-801. [PubMed: 15362035] [MGI Ref ID J:93577]
Dubois B; Chapat L; Goubier A; Papiernik M; Nicolas JF; Kaiserlian D. 2003. Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. Blood 102(9):3295-301. [PubMed: 12855551] [MGI Ref ID J:115675]
Eaton KA; Mefford M; Thevenot T. 2001. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 166(12):7456-61. [PubMed: 11390498] [MGI Ref ID J:124425]
El Kasmi KC; Holst J; Coffre M; Mielke L; de Pauw A; Lhocine N; Smith AM; Rutschman R; Kaushal D; Shen Y; Suda T; Donnelly RP; Myers MG Jr; Alexander W; Vignali DA; Watowich SS; Ernst M; Hilton DJ; Murray PJ. 2006. General nature of the STAT3-activated anti-inflammatory response. J Immunol 177(11):7880-8. [PubMed: 17114459] [MGI Ref ID J:140695]
El Kasmi KC; Smith AM; Williams L; Neale G; Panopolous A; Watowich SS; Hacker H; Foxwell BM; Murray PJ. 2007. Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. J Immunol 179(11):7215-9. [PubMed: 18025162] [MGI Ref ID J:133009]
Elliott DE; Setiawan T; Metwali A; Blum A; Urban JF Jr; Weinstock JV. 2004. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 34(10):2690. [PubMed: 15368285] [MGI Ref ID J:92338]
Eming SA; Werner S; Bugnon P; Wickenhauser C; Siewe L; Utermohlen O; Davidson JM; Krieg T; Roers A. 2007. Accelerated wound closure in mice deficient for interleukin-10. Am J Pathol 170(1):188-202. [PubMed: 17200193] [MGI Ref ID J:117053]
Endharti AT; Rifa'I M st; Shi Z; Fukuoka Y; Nakahara Y; Kawamoto Y; Takeda K; Isobe K; Suzuki H. 2005. Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 175(11):7093-7. [PubMed: 16301610] [MGI Ref ID J:122202]
Fang Y; Sharp GC; Braley-Mullen H. 2008. Interleukin-10 promotes resolution of granulomatous experimental autoimmune thyroiditis. Am J Pathol 172(6):1591-602. [PubMed: 18467701] [MGI Ref ID J:136188]
Fillatreau S; Sweenie CH; McGeachy MJ; Gray D; Anderton SM. 2002. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3(10):944-50. [PubMed: 12244307] [MGI Ref ID J:79219]
Fitzgerald DC; Zhang GX; El-Behi M; Fonseca-Kelly Z; Li H; Yu S; Saris CJ; Gran B; Ciric B; Rostami A. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 8(12):1372-9. [PubMed: 17994023] [MGI Ref ID J:127773]
Flanagan K; Modrusan Z; Cornelius J; Chavali A; Kasman I; Komuves L; Mo L; Diehl L. 2008. Intestinal Epithelial Cell Up-Regulation of LY6 Molecules during Colitis Results in Enhanced Chemokine Secretion. J Immunol 180(6):3874-81. [PubMed: 18322195] [MGI Ref ID J:133031]
Flano E; Kayhan B; Woodland DL; Blackman MA. 2005. Infection of dendritic cells by a gamma2-herpesvirus induces functional modulation. J Immunol 175(5):3225-34. [PubMed: 16116213] [MGI Ref ID J:113212]
Foulds KE; Rotte MJ; Seder RA. 2006. IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection. J Immunol 177(4):2565-74. [PubMed: 16888018] [MGI Ref ID J:138354]
French AR; Sjolin H; Kim S; Koka R; Yang L; Young DA; Cerboni C; Tomasello E; Ma A; Vivier E; Karre K; Yokoyama WM. 2006. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J Immunol 177(8):4981-90. [PubMed: 17015680] [MGI Ref ID J:139300]
Freyschmidt-Paul P; McElwee KJ; Happle R; Kissling S; Wenzel E; Sundberg JP; Zoller M; Hoffmann R. 2002. Interleukin-10-deficient mice are less susceptible to the induction of alopecia areata. J Invest Dermatol 119(4):980-2. [PubMed: 12406350] [MGI Ref ID J:80138]
Froicu M; Weaver V; Wynn TA; McDowell MA; Welsh JE; Cantorna MT. 2003. A crucial role for the vitamin d receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17(12):2386-92. [PubMed: 14500760] [MGI Ref ID J:86860]
Froicu M; Zhu Y; Cantorna MT. 2006. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology 117(3):310-8. [PubMed: 16476050] [MGI Ref ID J:107077]
Fujiwara H; Yamazaki T; Uzawa A; Nagata K; Kobayashi Y. 2008. Transient infiltration of neutrophils into the thymus following whole-body X-ray irradiation in IL-10 knockout mice. Biochem Biophys Res Commun 369(2):432-6. [PubMed: 18291100] [MGI Ref ID J:134174]
Gao Y; Herndon JM; Zhang H; Griffith TS; Ferguson TA. 1998. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J Exp Med 188(5):887-96. [PubMed: 9730890] [MGI Ref ID J:112021]
Gazzinelli RT; Wysocka M; Hieny S; Scharton-Kersten T; Cheever A; Kuhn R; Muller W; Trinchieri G; Sher A. 1996. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 157(2):798-805. [PubMed: 8752931] [MGI Ref ID J:34041]
Gjertsson I; Hultgren OH; Tarkowski A. 2002. Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance. Clin Exp Immunol 130(3):409-14. [PubMed: 12452830] [MGI Ref ID J:131892]
Gonnella PA; Waldner HP; Kodali D; Weiner HL. 2004. Induction of low dose oral tolerance in IL-10 deficient mice with experimental autoimmune encephalomyelitis. J Autoimmun 23(3):193-200. [PubMed: 15501390] [MGI Ref ID J:93230]
Gonzalez A; Andre-Schmutz I; Carnaud C; Mathis D; Benoist C. 2001. Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes. Nat Immunol 2(12):1117-25. [PubMed: 11713466] [MGI Ref ID J:109860]
Gourdy P; Schambourg A; Filipe C; Douin-Echinard V; Garmy-Susini B; Calippe B; Terce F; Bayard F; Arnal JF. 2007. Transforming growth factor activity is a key determinant for the effect of estradiol on fatty streak deposit in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 27(10):2214-21. [PubMed: 17690314] [MGI Ref ID J:134877]
Grilli M; Barbieri I; Basudev H; Brusa R; Casati C; Lozza G; Ongini E. 2000. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci 12(7):2265-72. [PubMed: 10947805] [MGI Ref ID J:108086]
Grimbaldeston MA; Nakae S; Kalesnikoff J; Tsai M; Galli SJ. 2007. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8(10):1095-104. [PubMed: 17767162] [MGI Ref ID J:125267]
Grunig G; Corry DB; Leach MW; Seymour BW; Kurup VP; Rennick DM. 1997. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 185(6):1089-99. [PubMed: 9091582] [MGI Ref ID J:39230]
Gu Y; Yang J; Ouyang X; Liu W; Li H; Yang J; Bromberg J; Chen SH; Mayer L; Unkeless JC; Xiong H. 2008. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol 38(7):1807-13. [PubMed: 18506885] [MGI Ref ID J:137290]
Gudmundsson G; Bosch A; Davidson BL; Berg DJ; Hunninghake GW. 1998. Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice. Am J Respir Cell Mol Biol 19(5):812-8. [PubMed: 9806746] [MGI Ref ID J:114214]
Guerrero A; Fries BC. 2008. Phenotypic switching in Cryptococcus neoformans contributes to virulence by changing the immunological host response. Infect Immun 76(9):4322-31. [PubMed: 18591227] [MGI Ref ID J:138887]
Guilbault C; Stotland P; Lachance C; Tam M; Keller A; Thompson-Snipes L; Cowley E; Hamilton TA; Eidelman DH; Stevenson MM; Radzioch D. 2002. Influence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice. Immunology 107(3):297-305. [PubMed: 12423305] [MGI Ref ID J:113617]
Gunnett CA; Berg DJ; Faraci FM; Feuerstein G. 1999. Vascular effects of lipopolysaccharide are enhanced in interleukin-10-deficient mice. Stroke 30(10):2191-5; discussion 2195-6. [PubMed: 10512928] [MGI Ref ID J:59742]
Gunnett CA; Heistad DD; Berg DJ; Faraci FM. 2000. IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation Am J Physiol Heart Circ Physiol 279(4):H1555-62. [PubMed: 11009441] [MGI Ref ID J:65225]
Gunnett CA; Lund DD; Faraci FM; Heistad DD. 2005. Vascular interleukin-10 protects against LPS-induced vasomotor dysfunction. Am J Physiol Heart Circ Physiol 289(2):H624-30. [PubMed: 16014616] [MGI Ref ID J:100322]
Haggqvist B; Hultman P. 2005. Interleukin-10 in murine metal-induced systemic autoimmunity. Clin Exp Immunol 141(3):422-31. [PubMed: 16045731] [MGI Ref ID J:100639]
Hamano S; Asgharpour A; Stroup SE; Wynn TA; Leiter EH; Houpt E. 2006. Resistance of C57BL/6 mice to amoebiasis is mediated by nonhemopoietic cells but requires hemopoietic IL-10 production. J Immunol 177(2):1208-13. [PubMed: 16818779] [MGI Ref ID J:134990]
Hammer M; Mages J; Dietrich H; Schmitz F; Striebel F; Murray PJ; Wagner H; Lang R. 2005. Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10. Eur J Immunol 35(10):2991-3001. [PubMed: 16184516] [MGI Ref ID J:113501]
Hao S; Yuan J; Xu S; Munegowda MA; Deng Y; Gordon J; Xing Z; Xiang J. 2008. Antigen specificity acquisition of adoptive CD4+ regulatory T cells via acquired peptide-MHC class I complexes. J Immunol 181(4):2428-37. [PubMed: 18684933] [MGI Ref ID J:140189]
Harrington LE; Hatton RD; Mangan PR; Turner H; Murphy TL; Murphy KM; Weaver CT. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6(11):1123-32. [PubMed: 16200070] [MGI Ref ID J:112601]
Hasko G; Szabo C; Nemeth ZH; Salzman AL; Vizi ES. 1998. Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent. Eur J Immunol 28(2):468-72. [PubMed: 9521054] [MGI Ref ID J:46196]
Hata H; Sakaguchi N; Yoshitomi H; Iwakura Y; Sekikawa K; Azuma Y; Kanai C; Moriizumi E; Nomura T; Nakamura T; Sakaguchi S. 2004. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114(4):582-8. [PubMed: 15314695] [MGI Ref ID J:92002]
Hegazi RA; Mady HH; Melhem MF; Sepulveda AR; Mohi M; Kandil HM. 2003. Celecoxib and rofecoxib potentiate chronic colitis and premalignant changes in interleukin 10 knockout mice. Inflamm Bowel Dis 9(4):230-6. [PubMed: 12902846] [MGI Ref ID J:85702]
Hegazi RA; Rao KN; Mayle A; Sepulveda AR; Otterbein LE; Plevy SE. 2005. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med 202(12):1703-13. [PubMed: 16365149] [MGI Ref ID J:118826]
Helmby H; Grencis RK. 2003. Contrasting roles for IL-10 in protective immunity to different life cycle stages of intestinal nematode parasites. Eur J Immunol 33(9):2382-90. [PubMed: 12938214] [MGI Ref ID J:85455]
Hernandez Y; Arora S; Erb-Downward JR; McDonald RA; Toews GB; Huffnagle GB. 2005. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol 174(2):1027-36. [PubMed: 15634927] [MGI Ref ID J:95831]
Hesse M; Modolell M; La Flamme AC; Schito M; Fuentes JM; Cheever AW; Pearce EJ; Wynn TA. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 167(11):6533-44. [PubMed: 11714822] [MGI Ref ID J:72822]
Hickey MJ; Issekutz AC; Reinhardt PH; Fedorak RN; Kubes P. 1998. Endogenous interleukin-10 regulates hemodynamic parameters, leukocyte-endothelial cell interactions, and microvascular permeability during endotoxemia. Circ Res 83(11):1124-31. [PubMed: 9831707] [MGI Ref ID J:114199]
Hirotani T; Lee PY; Kuwata H; Yamamoto M; Matsumoto M; Kawase I; Akira S; Takeda K. 2005. The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J Immunol 174(6):3650-7. [PubMed: 15749903] [MGI Ref ID J:97704]
Hoentjen F; Sartor RB; Ozaki M; Jobin C. 2005. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood 105(2):689-96. [PubMed: 15251981] [MGI Ref ID J:96516]
Hoffmann KF; Cheever AW; Wynn TA. 2000. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 164(12):6406-16. [PubMed: 10843696] [MGI Ref ID J:124519]
Hoffmann KF; James SL; Cheever AW; Wynn TA. 1999. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol 163(2):927-38. [PubMed: 10395689] [MGI Ref ID J:56157]
Hu S; Ciancio MJ; Lahav M; Fujiya M; Lichtenstein L; Anant S; Musch MW; Chang EB. 2007. Translational inhibition of colonic epithelial heat shock proteins by IFN-gamma and TNF-alpha in intestinal inflammation. Gastroenterology 133(6):1893-904. [PubMed: 18054561] [MGI Ref ID J:135619]
Huang EH; Park JC; Appelman H; Weinberg AD; Banerjee M; Logsdon CD; Schmidt AM. 2006. Induction of inflammatory bowel disease accelerates adenoma formation in Min +/- mice. Surgery 139(6):782-8. [PubMed: 16782435] [MGI Ref ID J:115828]
Hunter CA; Ellis-Neyes LA; Slifer T; Kanaly S; Grunig G; Fort M; Rennick D; Araujo FG. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 158(7):3311-6. [PubMed: 9120288] [MGI Ref ID J:110835]
Igietseme JU; Ananaba GA; Bolier J; Bowers S; Moore T; Belay T; Eko FO; Lyn D; Black CM. 2000. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development. J Immunol 164(8):4212-9. [PubMed: 10754317] [MGI Ref ID J:123433]
Inoue S; Leitner WW; Golding B; Scott D. 2006. Inhibitory effects of B cells on antitumor immunity. Cancer Res 66(15):7741-7. [PubMed: 16885377] [MGI Ref ID J:112103]
Ismail HF; Fick P; Zhang J; Lynch RG; Berg DJ. 2003. Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J Immunol 170(7):3782-9. [PubMed: 12646644] [MGI Ref ID J:125444]
Ismail HF; Zhang J; Lynch RG; Wang Y; Berg DJ. 2003. Role for complement in development of Helicobacter-induced gastritis in interleukin-10-deficient mice. Infect Immun 71(12):7140-8. [PubMed: 14638805] [MGI Ref ID J:86649]
Jankovic D; Kullberg MC; Feng CG; Goldszmid RS; Collazo CM; Wilson M; Wynn TA; Kamanaka M; Flavell RA; Sher A. 2007. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204(2):273-83. [PubMed: 17283209] [MGI Ref ID J:125371]
Jankovic D; Kullberg MC; Hieny S; Caspar P; Collazo CM; Sher A. 2002. In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting. Immunity 16(3):429-39. [PubMed: 11911827] [MGI Ref ID J:113516]
Jeyarajah DR; Kielar ML; Saboorian H; Karimi P; Frantz N; Lu CY. 2006. Impact of bile duct obstruction on hepatic E. coli infection: role of IL-10. Am J Physiol Gastrointest Liver Physiol 291(1):G91-4. [PubMed: 16769814] [MGI Ref ID J:111075]
Jimenez Mdel P; Walls L; Fierer J. 2006. High levels of interleukin-10 impair resistance to pulmonary coccidioidomycosis in mice in part through control of nitric oxide synthase 2 expression. Infect Immun 74(6):3387-95. [PubMed: 16714569] [MGI Ref ID J:109235]
Joffre O; Santolaria T; Calise D; Al Saati T; Hudrisier D; Romagnoli P; van Meerwijk JP. 2008. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 14(1):88-92. [PubMed: 18066074] [MGI Ref ID J:130486]
Johansson AC; Hansson AS; Nandakumar KS; Backlund J; Holmdahl R. 2001. Il-10-deficient b10.q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type ii collagen antibodies. J Immunol 167(6):3505-12. [PubMed: 11544344] [MGI Ref ID J:71518]
Jones DE; Ackermann MR; Wille U; Hunter CA; Scott P. 2002. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun 70(4):2151-8. [PubMed: 11895981] [MGI Ref ID J:75483]
Jones SP; Trocha SD; Lefer DJ. 2001. Cardioprotective actions of endogenous IL-10 are independent of iNOS. Am J Physiol Heart Circ Physiol 281(1):H48-52. [PubMed: 11406467] [MGI Ref ID J:70292]
Jung YJ; Ryan L; LaCourse R; North RJ. 2003. Increased interleukin-10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice. Immunology 109(2):295-9. [PubMed: 12757625] [MGI Ref ID J:83724]
Justice JP; Shibata Y; Sur S; Mustafa J; Fan M; Van Scott MR. 2001. IL-10 gene knockout attenuates allergen-induced airway hyperresponsiveness in C57BL/6 mice. Am J Physiol Lung Cell Mol Physiol 280(2):L363-8. [PubMed: 11159016] [MGI Ref ID J:68061]
Kabbur PM; Carson WF th; Guernsey L; Secor ER Jr; Thrall RS; Schramm CM. 2006. Interleukin-10 does not mediate inhalational tolerance in a chronic model of ovalbumin-induced allergic airway disease. Cell Immunol 239(1):67-74. [PubMed: 16765924] [MGI Ref ID J:110165]
Kamada N; Hisamatsu T; Okamoto S; Sato T; Matsuoka K; Arai K; Nakai T; Hasegawa A; Inoue N; Watanabe N; Akagawa KS; Hibi T. 2005. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol 175(10):6900-8. [PubMed: 16272349] [MGI Ref ID J:119692]
Kane MM; Mosser DM. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166(2):1141-7. [PubMed: 11145695] [MGI Ref ID J:66849]
Kapp JA; Honjo K; Kapp LM; Xu X; Cozier A; Bucy RP. 2006. TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection. Int Immunol 18(11):1549-62. [PubMed: 16966495] [MGI Ref ID J:114951]
Karrasch T; Kim JS; Jang BI; Jobin C. 2007. The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB(EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules. PLoS ONE 2(7):e596. [PubMed: 17611628] [MGI Ref ID J:129302]
Kato A; Okaya T; Lentsch AB. 2003. Endogenous IL-13 protects hepatocytes and vascular endothelial cells during ischemia/reperfusion injury. Hepatology 37(2):304-12. [PubMed: 12540780] [MGI Ref ID J:105813]
Kawachi S; Jennings S; Panes J; Cockrell A; Laroux FS; Gray L; Perry M; van der Heyde H; Balish E; Granger DN; Specian RA; Grisham MB. 2000. Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice. Am J Physiol Gastrointest Liver Physiol 278(5):G734-43. [PubMed: 10801266] [MGI Ref ID J:108662]
Kearley J; Barker JE; Robinson DS; Lloyd CM. 2005. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 202(11):1539-47. [PubMed: 16314435] [MGI Ref ID J:118855]
Kellermann SA; McEvoy LM. 2001. The Peyer's patch microenvironment suppresses T cell responses to chemokines and other stimuli. J Immunol 167(2):682-90. [PubMed: 11441071] [MGI Ref ID J:120507]
Kelly J; Ali Khan A; Yin J; Ferguson TA; Apte RS. 2007. Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J Clin Invest 117(11):3421-6. [PubMed: 17975672] [MGI Ref ID J:127374]
Kim SC; Tonkonogy SL; Albright CA; Tsang J; Balish EJ; Braun J; Huycke MM; Sartor RB. 2005. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128(4):891-906. [PubMed: 15825073] [MGI Ref ID J:97309]
Kontoyiannis D; Kotlyarov A; Carballo E; Alexopoulou L; Blackshear PJ; Gaestel M; Davis R; Flavell R; Kollias G. 2001. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J 20(14):3760-70. [PubMed: 11447117] [MGI Ref ID J:108402]
Kosiewicz MM; Alard P; Liang S; Clark SL. 2004. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand. Int Immunol 16(5):697-706. [PubMed: 15096489] [MGI Ref ID J:89454]
Kraus TA; Brimnes J; Muong C; Liu JH; Moran TM; Tappenden KA; Boros P; Mayer L. 2005. Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J Clin Invest 115(8):2234-2243. [PubMed: 16041410] [MGI Ref ID J:100225]
Kryczek I; Wei S; Zou L; Zhu G; Mottram P; Xu H; Chen L; Zou W. 2006. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol 177(1):40-4. [PubMed: 16785496] [MGI Ref ID J:134411]
Krzyszton CP; Sparkman NL; Grant RW; Buchanan JB; Broussard SR; Woods J; Johnson RW. 2008. Exacerbated fatigue and motor deficits in interleukin-10-deficient mice after peripheral immune stimulation. Am J Physiol Regul Integr Comp Physiol 295(4):R1109-14. [PubMed: 18650318] [MGI Ref ID J:139972]
Kuhn R; Lohler J; Rennick D; Rajewsky K; Muller W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis [see comments] Cell 75(2):263-74. [PubMed: 8402911] [MGI Ref ID J:15222]
Kuwata H; Watanabe Y; Miyoshi H; Yamamoto M; Kaisho T; Takeda K; Akira S. 2003. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 102(12):4123-9. [PubMed: 12907458] [MGI Ref ID J:86681]
Lampropoulou V; Hoehlig K; Roch T; Neves P; Gomez EC; Sweenie CH; Hao Y; Freitas AA; Steinhoff U; Anderton SM; Fillatreau S. 2008. TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity. J Immunol 180(7):4763-73. [PubMed: 18354200] [MGI Ref ID J:133381]
Lazarus JJ; Kay MA; McCarter AL; Wooten RM. 2008. Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect Immun 76(3):1153-62. [PubMed: 18086805] [MGI Ref ID J:131640]
Lazarus JJ; Meadows MJ; Lintner RE; Wooten RM. 2006. IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J Immunol 177(10):7076-85. [PubMed: 17082624] [MGI Ref ID J:140484]
Lee CG; Homer RJ; Cohn L; Link H; Jung S; Craft JE; Graham BS; Johnson TR; Elias JA. 2002. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem 277(38):35466-74. [PubMed: 12107190] [MGI Ref ID J:79116]
Lee CW; Rao VP; Rogers AB; Ge Z; Erdman SE; Whary MT; Fox JG. 2007. Wild-type and interleukin-10-deficient regulatory T cells reduce effector T-cell-mediated gastroduodenitis in Rag2-/- mice, but only wild-type regulatory T cells suppress Helicobacter pylori gastritis. Infect Immun 75(6):2699-707. [PubMed: 17353283] [MGI Ref ID J:121929]
Li C; Corraliza I; Langhorne J. 1999. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect Immun 67(9):4435-42. [PubMed: 10456884] [MGI Ref ID J:57118]
Liu Y; Bi X; Xu S; Xiang J. 2005. Tumor-infiltrating dendritic cell subsets of progressive or regressive tumors induce suppressive or protective immune responses. Cancer Res 65(11):4955-62. [PubMed: 15930318] [MGI Ref ID J:98765]
Liva SM; Voskuhl RR. 2001. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol 167(4):2060-7. [PubMed: 11489988] [MGI Ref ID J:120413]
Londono D; Marques A; Hornung RL; Cadavid D. 2008. IL-10 helps control pathogen load during high-level bacteremia. J Immunol 181(3):2076-83. [PubMed: 18641346] [MGI Ref ID J:139233]
Loser K; Apelt J; Voskort M; Mohaupt M; Balkow S; Schwarz T; Grabbe S; Beissert S. 2007. IL-10 controls ultraviolet-induced carcinogenesis in mice. J Immunol 179(1):365-71. [PubMed: 17579057] [MGI Ref ID J:125760]
Louis H; Van Laethem JL; Wu W; Quertinmont E; Degraef C; Van den Berg K; Demols A; Goldman M; Le Moine O; Geerts A; Deviere J. 1998. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 28(6):1607-15. [PubMed: 9828225] [MGI Ref ID J:106536]
Ly LH; Smith R rd; Chapkin RS; McMurray DN. 2005. Dietary n-3 polyunsaturated fatty acids suppress splenic CD4(+) T cell function in interleukin (IL)-10(-/-) mice. Clin Exp Immunol 139(2):202-9. [PubMed: 15654818] [MGI Ref ID J:105106]
Lytle C; Tod TJ; Vo KT; Lee JW; Atkinson RD; Straus DS. 2005. The Peroxisome Proliferator-Activated Receptor gamma Ligand Rosiglitazone Delays the Onset of Inflammatory Bowel Disease in Mice with Interleukin 10 Deficiency. Inflamm Bowel Dis 11(3):231-43. [PubMed: 15735429] [MGI Ref ID J:97868]
Machado FS; Esper L; Dias A; Madan R; Gu Y; Hildeman D; Serhan CN; Karp CL; Aliberti J. 2008. Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6. J Exp Med 205(5):1077-86. [PubMed: 18411340] [MGI Ref ID J:136277]
Madsen KL; Doyle JS; Jewell LD; Tavernini MM; Fedorak RN. 1999. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116(5):1107-14. [PubMed: 10220502] [MGI Ref ID J:106688]
Madsen KL; Doyle JS; Tavernini MM; Jewell LD; Rennie RP; Fedorak RN. 2000. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 118(6):1094-105. [PubMed: 10833484] [MGI Ref ID J:107748]
Madsen KL; Malfair D; Gray D; Doyle JS; Jewell LD; Fedorak RN. 1999. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis 5(4):262-70. [PubMed: 10579119] [MGI Ref ID J:59872]
Maeda A; Beissert S; Schwarz T; Schwarz A. 2008. Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells. J Immunol 180(5):3065-71. [PubMed: 18292529] [MGI Ref ID J:131531]
Mahler M; Most C; Schmidtke S; Sundberg J; Li R; Hedrich H; Churchill G. 2002. Genetics of Colitis Susceptibility in IL-10-Deficient Mice: Backcross versus F2 Results Contrasted by Principal Component Analysis. Genomics 80(3):274. [PubMed: 12213197] [MGI Ref ID J:78917]
Makela MJ; Kanehiro A; Borish L; Dakhama A; Loader J; Joetham A; Xing Z; Jordana M; Larsen GL; Gelfand EW. 2000. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization. Proc Natl Acad Sci U S A 97(11):6007-12. [PubMed: 10811896] [MGI Ref ID J:62283]
Mansfield LS; Bell JA; Wilson DL; Murphy AJ; Elsheikha HM; Rathinam VA; Fierro BR; Linz JE; Young VB. 2007. C57BL/6 and Congenic Interleukin-10-Deficient Mice Can Serve as Models of Campylobacter jejuni Colonization and Enteritis. Infect Immun 75(3):1099-115. [PubMed: 17130251] [MGI Ref ID J:118502]
Martin ME; Caspersen K; Dumler JS. 2001. Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am J Pathol 158(5):1881-8. [PubMed: 11337387] [MGI Ref ID J:69104]
Matlack R; Yeh K; Rosini L; Gonzalez D; Taylor J; Silberman D; Pennello A; Riggs J. 2006. Peritoneal macrophages suppress T-cell activation by amino acid catabolism. Immunology 117(3):386-95. [PubMed: 16476058] [MGI Ref ID J:107076]
Matsumura Y; Byrne SN; Nghiem DX; Miyahara Y; Ullrich SE. 2006. A role for inflammatory mediators in the induction of immunoregulatory B cells. J Immunol 177(7):4810-7. [PubMed: 16982922] [MGI Ref ID J:139306]
Maurer M; Seidel-Guyenot W; Metz M; Knop J; Steinbrink K. 2003. Critical role of IL-10 in the induction of low zone tolerance to contact allergens. J Clin Invest 112(3):432-9. [PubMed: 12865418] [MGI Ref ID J:118509]
Maynard CL; Harrington LE; Janowski KM; Oliver JR; Zindl CL; Rudensky AY; Weaver CT. 2007. Regulatory T cells expressing interleukin 10 develop from Foxp3(+) and Foxp3(-) precursor cells in the absence of interleukin 10. Nat Immunol 8(9):931-41. [PubMed: 17694059] [MGI Ref ID J:124255]
McBride S; Hoebe K; Georgel P; Janssen E. 2006. Cell-associated double-stranded RNA enhances antitumor activity through the production of type I IFN. J Immunol 177(9):6122-8. [PubMed: 17056539] [MGI Ref ID J:140522]
McCafferty DM; Sihota E; Muscara M; Wallace JL; Sharkey KA; Kubes P. 2000. Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am J Physiol Gastrointest Liver Physiol 279(1):G90-9. [PubMed: 10898750] [MGI Ref ID J:107861]
McGeachy MJ; Bak-Jensen KS; Chen Y; Tato CM; Blumenschein W; McClanahan T; Cua DJ. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8(12):1390-7. [PubMed: 17994024] [MGI Ref ID J:127772]
Mencacci A; Montagnoli C; Bacci A; Cenci E; Pitzurra L; Spreca A; Kopf M; Sharpe AH; Romani L. 2002. CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J Immunol 169(6):3180-90. [PubMed: 12218136] [MGI Ref ID J:120204]
Mesples B; Plaisant F; Gressens P. 2003. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Brain Res Dev Brain Res 141(1-2):25-32. [PubMed: 12644245] [MGI Ref ID J:82655]
Minami M; Shimizu K; Okamoto Y; Folco E; Ilasaca ML; Feinberg MW; Aikawa M; Libby P. 2008. Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation. J Biol Chem 283(15):9692-703. [PubMed: 18270204] [MGI Ref ID J:135247]
Mizoguchi A; Mizoguchi E; Takedatsu H; Blumberg RS; Bhan AK. 2002. Chronic Intestinal Inflammatory Condition Generates IL-10-Producing Regulatory B Cell Subset Characterized by CD1d Upregulation. Immunity 16(2):219-30. [PubMed: 11869683] [MGI Ref ID J:74718]
Montufar-Solis D; Schaefer J; Hicks MJ; Klein JR. 2008. Massive but selective cytokine dysregulation in the colon of IL-10 / mice revealed by multiplex analysis. Int Immunol 20(1):141-54. [PubMed: 18046045] [MGI Ref ID J:129200]
Morise Z; Eppihimer M; Granger DN; Anderson DC; Grisham MB. 1999. Effects of lipopolysaccharide on endothelial cell adhesion molecule expression in interleukin-10 deficient mice. Inflammation 23(2):99-110. [PubMed: 10213266] [MGI Ref ID J:56218]
Mucida D; Kutchukhidze N; Erazo A; Russo M; Lafaille JJ; Curotto de Lafaille MA. 2005. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 115(7):1923-33. [PubMed: 15937545] [MGI Ref ID J:99807]
Muhlbauer M; Chilton PM; Mitchell TC; Jobin C. 2008. Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23P19 gene expression in IL-10(-/-) mice. J Biol Chem 283(21):14182-9. [PubMed: 18375954] [MGI Ref ID J:137573]
Murphy ML; Wille U; Villegas EN; Hunter CA; Farrell JP. 2001. IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol 31(10):2848-56. [PubMed: 11592059] [MGI Ref ID J:72355]
Murphy SP; Fast LD; Hanna NN; Sharma S. 2005. Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol 175(6):4084-90. [PubMed: 16148158] [MGI Ref ID J:116699]
Murray PJ; Young RA. 1999. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 67(6):3087-95. [PubMed: 10338525] [MGI Ref ID J:55136]
Myers D Jr; Farris D; Hawley A; Wrobleski S; Chapman A; Stoolman L; Knibbs R; Strieter R; Wakefield T. 2002. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res 108(2):212-21. [PubMed: 12505044] [MGI Ref ID J:103110]
Nagamine CM; Rogers AB; Fox JG; Schauer DB. 2008. Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice. Int J Cancer 122(4):832-8. [PubMed: 17957786] [MGI Ref ID J:135558]
Narushima S; DiMeo D; Tian J; Zhang J; Liu D; Berg DJ. 2008. 5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10-/- mice. Am J Physiol Gastrointest Liver Physiol 294(2):G477-88. [PubMed: 18048478] [MGI Ref ID J:132202]
Narushima S; Spitz DR; Oberley LW; Toyokuni S; Miyata T; Gunnett CA; Buettner GR; Zhang J; Ismail H; Lynch RG; Berg DJ. 2003. Evidence for oxidative stress in NSAID-induced colitis in IL10-/- mice. Free Radic Biol Med 34(9):1153-66. [PubMed: 12706496] [MGI Ref ID J:119439]
Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M. 2007. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis. Gastroenterology 132(1):176-89. [PubMed: 17241870] [MGI Ref ID J:128223]
Niikura M; Kamiya S; Kita K; Kobayashi F. 2008. Coinfection with nonlethal murine malaria parasites suppresses pathogenesis caused by Plasmodium berghei NK65. J Immunol 180(10):6877-84. [PubMed: 18453608] [MGI Ref ID J:134868]
Noben-Trauth N; Lira R; Nagase H; Paul WE; Sacks DL. 2003. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J Immunol 170(10):5152-8. [PubMed: 12734362] [MGI Ref ID J:123822]
North RJ. 1998. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 113(1):55-8. [PubMed: 9697983] [MGI Ref ID J:114201]
O'Mahony L; Feeney M; O'Halloran S; Murphy L; Kiely B; Fitzgibbon J; Lee G; O'Sullivan G; Shanahan F; Collins JK. 2001. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 15(8):1219-25. [PubMed: 11472326] [MGI Ref ID J:70926]
Oakley OR; Garvy BA; Humphreys S; Qureshi MH; Pomeroy C. 2008. Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus. Clin Exp Immunol 151(1):155-64. [PubMed: 18005264] [MGI Ref ID J:130172]
Ohtani M; Nagai S; Kondo S; Mizuno S; Nakamura K; Tanabe M; Takeuchi T; Matsuda S; Koyasu S. 2008. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 112(3):635-43. [PubMed: 18492954] [MGI Ref ID J:138434]
Okada K; Fujita T; Minamoto K; Liao H; Naka Y; Pinsky DJ. 2000. Potentiation of endogenous fibrinolysis and rescue from lung ischemia/reperfusion injury in interleukin (IL)-10-reconstituted IL-10 null mice. J Biol Chem 275(28):21468-76. [PubMed: 10806208] [MGI Ref ID J:63469]
Oldenburg B; van Berge Henegouwen GP; Rennick D; Van Asbeck BS; Koningsberger JC. 2000. Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest 30(6):505-10. [PubMed: 10849019] [MGI Ref ID J:103312]
Oppmann B; Lesley R; Blom B; Timans JC; Xu Y; Hunte B; Vega F; Yu N; Wang J; Singh K; Zonin F; Vaisberg E; Churakova T; Liu M; Gorman D; Wagner J; Zurawski S; Liu Y; Abrams JS; Moore KW; Rennick D; de Waal-Malefyt R; Hannum C; Bazan JF; Kastelein RA. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 Immunity 13(5):715-25. [PubMed: 11114383] [MGI Ref ID J:65966]
Otero DC; Poli V; David M; Rickert RC. 2006. Cutting edge: inherent and acquired resistance to radiation-induced apoptosis in B cells: a pivotal role for STAT3. J Immunol 177(10):6593-7. [PubMed: 17082570] [MGI Ref ID J:140502]
Padigel UM; Alexander J; Farrell JP. 2003. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J Immunol 171(7):3705-10. [PubMed: 14500669] [MGI Ref ID J:85625]
Padigel UM; Farrell JP. 2005. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells. J Immunol 174(10):6340-5. [PubMed: 15879134] [MGI Ref ID J:99049]
Panes J; Aceituno M; Gil F; Miquel R; Pique JM; Salas A; McLean P. 2007. Efficacy of an inhibitor of adhesion molecule expression (GI270384X) in the treatment of experimental colitis. Am J Physiol Gastrointest Liver Physiol 293(4):G739-48. [PubMed: 17656448] [MGI Ref ID J:126663]
Panthel K; Faller G; Haas R. 2003. Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunity. Infect Immun 71(2):794-800. [PubMed: 12540559] [MGI Ref ID J:81703]
Papiernik M; de Moraes ML; Pontoux C; Vasseur F; Penit C. 1998. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 10(4):371-8. [PubMed: 9620592] [MGI Ref ID J:110541]
Pasche B; Kalaydjiev S; Franz TJ; Kremmer E; Gailus-Durner V; Fuchs H; Hrabe de Angelis M; Lengeling A; Busch DH. 2005. Sex-dependent susceptibility to Listeria monocytogenes infection is mediated by differential interleukin-10 production. Infect Immun 73(9):5952-60. [PubMed: 16113316] [MGI Ref ID J:100414]
Peng JK; Lin JS; Kung JT; Finkelman FD; Wu-Hsieh BA. 2005. The combined effect of IL-4 and IL-10 suppresses the generation of, but does not change the polarity of, type-1 T cells in Histoplasma infection. Int Immunol 17(2):193-205. [PubMed: 15642955] [MGI Ref ID J:95565]
Perona-Wright G; Jenkins SJ; Crawford A; Gray D; Pearce EJ; MacDonald AS. 2006. Distinct sources and targets of IL-10 during dendritic cell-driven Th1 and Th2 responses in vivo. Eur J Immunol 36(9):2367-75. [PubMed: 16917957] [MGI Ref ID J:116745]
Perry JA; Olver CS; Burnett RC; Avery AC. 2005. Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation. J Immunol 174(10):5921-5. [PubMed: 15879082] [MGI Ref ID J:98996]
Pesce J; Kaviratne M; Ramalingam TR; Thompson RW; Urban JF Jr; Cheever AW; Young DA; Collins M; Grusby MJ; Wynn TA. 2006. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest 116(7):2044-55. [PubMed: 16778988] [MGI Ref ID J:111712]
Pimenta-Araujo R; Mascarell L; Huesca M; Cumano A; Bandeira A. 2002. Deoxyguanosine blocks allograft rejection of thymic epithelium but not lymphocyte infiltration and recognition. Eur J Immunol 32(1):77-86. [PubMed: 11754006] [MGI Ref ID J:73937]
Pontoux C; Banz A; Papiernik M. 2002. Natural CD4 CD25(+) regulatory T cells control the burst of superantigen-induced cytokine production: the role of IL-10. Int Immunol 14(2):233-9. [PubMed: 11809742] [MGI Ref ID J:113510]
Potteaux S; Esposito B; van Oostrom O; Brun V; Ardouin P; Groux H; Tedgui A; Mallat Z. 2004. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 24(8):1474-8. [PubMed: 15178562] [MGI Ref ID J:102225]
Pratt JS; Sachen KL; Wood HD; Eaton KA; Young VB. 2006. Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect Immun 74(8):4496-504. [PubMed: 16861635] [MGI Ref ID J:112296]
Qureshi MH; Harmsen AG; Garvy BA. 2003. IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection. J Immunol 170(2):1002-9. [PubMed: 12517967] [MGI Ref ID J:127133]
Raisanen-Sokolowski A; Glysing-Jensen T; Russell ME. 1998. Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice. Am J Pathol 153(5):1491-500. [PubMed: 9811341] [MGI Ref ID J:50766]
Raisanen-Sokolowski A; Mottram PL; Glysing-Jensen T; Satoskar A; Russell ME. 1997. Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection. J Clin Invest 100(10):2449-56. [PubMed: 9366559] [MGI Ref ID J:44346]
Rakoff-Nahoum S; Hao L; Medzhitov R. 2006. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25(2):319-29. [PubMed: 16879997] [MGI Ref ID J:113467]
Ramaswamy K; Kumar P; He YX. 2000. A role for parasite-induced PGE2 in IL-10-mediated host immunoregulation by skin stage schistosomula of Schistosoma mansoni. J Immunol 165(8):4567-74. [PubMed: 11035098] [MGI Ref ID J:118566]
Redpath S; Angulo A; Gascoigne NR; Ghazal P. 1999. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J Immunol 162(11):6701-7. [PubMed: 10352288] [MGI Ref ID J:112114]
Rhodes KA; Andrew EM; Newton DJ; Tramonti D; Carding SR. 2008. A subset of IL-10-producing gammadelta T cells protect the liver from Listeria-elicited, CD8(+) T cell-mediated injury. Eur J Immunol 38(8):2274-83. [PubMed: 18624301] [MGI Ref ID J:138563]
Rifa'i M; Shi Z; Zhang SY; Lee YH; Shiku H; Isobe K; Suzuki H. 2008. CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells. Int Immunol 20(7):937-47. [PubMed: 18495626] [MGI Ref ID J:137065]
Ring S; Schafer SC; Mahnke K; Lehr HA; Enk AH. 2006. CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur J Immunol 36(11):2981-92. [PubMed: 17048272] [MGI Ref ID J:117011]
Rizzo LV; Morawetz RA; Miller-Rivero NE; Choi R; Wiggert B; Chan CC; Morse HC rd; Nussenblatt RB; Caspi RR. 1999. IL-4 and IL-10 are both required for the induction of oral tolerance. J Immunol 162(5):2613-22. [PubMed: 10072503] [MGI Ref ID J:110850]
Roach DR; Martin E; Bean AG; Rennick DM; Briscoe H; Britton WJ. 2001. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand J Immunol 54(1-2):163-70. [PubMed: 11439163] [MGI Ref ID J:80909]
Roberts CT; White CA; Wiemer NG; Ramsay A; Robertson SA. 2003. Altered placental development in interleukin-10 null mutant mice. Placenta 24 Suppl A:S94-9. [PubMed: 12842419] [MGI Ref ID J:113180]
Robertson SA; Care AS; Skinner RJ. 2007. Interleukin 10 regulates inflammatory cytokine synthesis to protect against lipopolysaccharide-induced abortion and fetal growth restriction in mice. Biol Reprod 76(5):738-48. [PubMed: 17215490] [MGI Ref ID J:121947]
Robertson SA; Skinner RJ; Care AS. 2006. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 177(7):4888-96. [PubMed: 16982931] [MGI Ref ID J:139303]
Roelofs-Haarhuis K; Wu X; Gleichmann E. 2004. Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J Immunol 173(2):1043-50. [PubMed: 15240692] [MGI Ref ID J:91933]
Rothfuchs AG; Gigliotti D; Palmblad K; Andersson U; Wigzell H; Rottenberg ME. 2001. IFN-alphabeta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J Immunol 167(11):6453-61. [PubMed: 11714812] [MGI Ref ID J:72825]
Roy N; Barnett M; Knoch B; Dommels Y; McNabb W. 2007. Nutrigenomics applied to an animal model of Inflammatory Bowel Diseases: Transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutat Res 622(1-2):103-16. [PubMed: 17574631] [MGI Ref ID J:124308]
Rubtsov YP; Rasmussen JP; Chi EY; Fontenot J; Castelli L; Ye X; Treuting P; Siewe L; Roers A; Henderson WR Jr; Muller W; Rudensky AY. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28(4):546-58. [PubMed: 18387831] [MGI Ref ID J:134513]
Ruiz PA; Shkoda A; Kim SC; Sartor RB; Haller D. 2005. IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J Immunol 174(5):2990-9. [PubMed: 15728512] [MGI Ref ID J:97722]
Rynda A; Maddaloni M; Mierzejewska D; Ochoa-Reparaz J; Maslanka T; Crist K; Riccardi C; Barszczewska B; Fujihashi K; McGhee JR; Pascual DW. 2008. Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1. J Immunol 180